Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,400,449
+$257,268 QoQ
Shares Held
8,936
+19.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#525
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gladstone Institutional Advisory LLC holds $67,973,516 across 11 Drug Manufacturers - General names. NVS ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
19,736 | $23,671,952 | |
| 2 | JNJ |
Johnson & Johnson
|
52,767 | $13,401,234 | |
| 3 | MRK |
Merck & Co., Inc.
|
84,891 | $10,908,493 | |
| 4 | ABBV |
AbbVie Inc.
|
33,122 | $8,334,820 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
67,905 | $3,912,686 | |
| 6 | AMGN |
Amgen Inc
|
6,692 | $2,423,307 | |
| 7 | PFE |
Pfizer Inc
|
78,104 | $1,880,744 | |
| 8 | NVS |
Novartis AG
This page
|
8,936 | $1,400,449 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,400,449 | 8,936 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,143,181 | 7,484 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,213,118 | 8,799 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $966,031 | 7,533 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $853,967 | 7,057 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $787,271 | 7,062 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $678,931 | 6,977 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $824,348 | 7,167 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $774,177 | 7,272 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $645,672 | 6,675 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $796,653 | 7,890 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $825,269 | 8,102 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $824,131 | 8,167 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $757,252 | 8,231 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $735,920 | 8,112 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $609,828 | 8,023 | Shares | Sole | 2023-01-30 | |
| 2022-06-30 | $672,520 | 7,956 | Shares | Sole | 2023-01-30 | |
| 2022-03-31 | $811,687 | 9,250 | Shares | Sole | 2023-01-30 | |
| 2021-12-31 | $1,003,630 | 11,474 | Shares | Sole | 2023-01-30 | |
| 2021-09-30 | $1,191,289 | 14,567 | Shares | Sole | 2023-01-30 | |
| 2021-06-30 | $739,865 | 8,109 | Shares | Sole | 2023-01-30 | |
| 2021-03-31 | $375,770 | 4,396 | Shares | Sole | 2023-01-30 | |
| 2020-12-31 | $363,083 | 3,845 | Shares | Sole | 2023-01-30 | |
| 2020-09-30 | $373,493 | 4,295 | Shares | Sole | 2023-01-30 | |
| 2020-06-30 | $355,997 | 4,076 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $373,415 | 4,529 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||